Mountain High Acquisitions Corp. (MYHI)
OTC
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
▼ -99.00%
Market Cap
$220
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.43
52-Wk Range
1.0E-6-3.0E-4
CEO
Raymond Watt
Country
US
Currency
USD
Mountain High Acquisitions Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $0.00, down 99.00% on the session, giving a market capitalisation of $220. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -0.43 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.18
EV / EBITDA
-0.32
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-75.61
Current ratio
0.31
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2014-02-11
Headquarters
Scottsdale, AZ, US
About Mountain High Acquisitions Corp.
Mountain High Acquisitions Corp. primarily engages in identifying, acquiring, and developing various enterprises and assets within the burgeoning hemp sector. The company's operations are headquartered in Scottsdale, Arizona.
Comparable companies
Mountain High Acquisitions Corp. is most often compared with the following Healthcare names:
More research on MYHI
Open full interactive analysis & DCF →